Author: whatnews

jetcityimage/iStock Editorial via Getty Images Clinical-stage oncology company Fusion Pharmaceuticals (NASDAQ:FUSN) to be acquired by AstraZeneca (NASDAQ:AZN) for a price of $21.00 per share in cash at closing plus a non-transferable contingent value right of $3.00 per share in cash payable upon the achievement of a specified regulatory milestone. The upfront cash portion of the consideration represents a transaction value of ~$2B, a 97% premium to Fusion’s closing market price of $10.64 on March 18, 2024, and an 85% premium to the 30-day volume-weighted average price of $11.37 before this announcement. Combined, the upfront and maximum potential contingent value payments…

Read More

Aegon (NYSE:AEG) exercises its right to redeem €700M of 4% fixed-to-floating subordinated notes.The redemption of these grandfathered Tier 2 securities will be effective as of April 25, 2024, when the aggregate principal amount of €700M will be repaid, together with any accrued and unpaid interest.Aegon (AEG) intends to refinance the notes. Source link

Read More

Rama Steel Tubes shares jumped over 12% on Tuesday as the stock traded ex-bonus with respect to its 2:1 bonus issue.The company also fixed today as the record date to determine the shareholders eligible to receive the bonus shares.The bonus shares after their allotment will rank pari-passu in all respects and carry the same rights as the existing equity shares, the company said in its filing to the exchanges.The company’s board had on January 24 approved the issuance of bonus shares in the proportion of 2: 1.Total number of securities proposed to be issued is worth Rs 103.61 crore. Bonus…

Read More

KLA (NASDAQ:KLAC) to exit the company’s flat panel display or FPD business that is part of its PCB, Display and Component Inspection reporting segment. The company expects to complete the exit through end of manufacturing of FPD products by December 31, 2024. The company will continue to provide services to the installed base for the discontinued product lines. The decision is based on multiple factors, including the cancellation of a significant new technology project by a major customer, investigating alternatives for FPD business. The FPD business accounted for 1.4% of the company’s total revenue in calendar year 2023. The stock…

Read More

Nikada Japan (NKY:IND) +0.41%. Japan’s central bank hikes the interest rate after 17 years and scraps yield curve control. The BOJ also stopped ETF and J-REIT purchases and plans to gradually reduce corporate bond buying. Japan’s industrial output fell 6.7% in January, less than an initial estimate. China (SHCOMP) -0.37%. Hong Kong (HSI) -0.94%. India (SENSEX) -0.77%. Investors cautiously anticipated preliminary readings for the manufacturing and services sectors in India during March later this week. Australia (AS51) +0.36%. The Reserve Bank of Australia keeps interest rates on hold at 4.35%, standing pat for the third consecutive meeting. In the U.S.…

Read More

Clinical-stage biotechnology company Arvinas (NASDAQ:ARVN) appointed Noah Berkowitz, M.D., Ph.D., to the role of chief medical officer and a member of the executive committee reporting to president and CEO John Houston, Ph.D. effective today. Dr. Berkowitz will lead the ongoing clinical development of Arvinas’ PROTAC protein degrader programs in oncology and neuroscience. The company also announced that Ron Peck, M.D., who was chief medical officer since joining Arvinas in mid-2019, will be leaving to pursue other opportunities. More on Arvinas Source link

Read More

NEW YORK – Jan. 6, 2023: Nate Anderson works at his desk. Anderson exposes corporate fraud and ponzi schemes through his company Hindenburg Research.The Washington Post | The Washington Post | Getty ImagesHindenburg Research has established itself as one of the most powerful voices in public activist short-selling, hammering the share prices of multiple big name companies in recent years with its blockbuster reports.The New York-based activist short-seller, founded by Nate Anderson, has also developed a reputation for its fearlessness, having gone after billionaires like Carl Icahn and Gautam Adani, along with regularly launching big public short bets and serious…

Read More

Submitting Form 12BB to your employer on time can significantly reduce TDS for the majority of the year. Photo: Shutterstock The government introduced the new tax regime to streamline the process of filing taxes, aiming to make it more straightforward for taxpayers. The main goal was to simplify the tax filing experience by eliminating the need for taxpayers to navigate through numerous deductions and exemptions to decrease their taxable income. Instead, the focus shifted to offering reduced tax rates. In this overhaul, deductions for expenses such as rent, travel, medical, certain allowances, and interest on loans for self-occupied properties were…

Read More

Pharma-Bio Serv press release (OTCQB:PBSV): Q1 net loss for the quarter ended January 31, 2024 was approximately $0.27M compared to a net income of approximately $0.43M for the same period last year. Revenue of $2.4M, a decrease of approximately $1.9M when compared to the same period last year. Source link

Read More